News Category
HPTN 084 Study Demonstrates Superiority of CAB LA to Oral FTC/TDF for the Prevention of HIV
HPTN 084 Results Press Release PDF
Dr Seatla presents study to NIH Director
The Botswana Harvard AIDS Institute Partnership (BHP)’s Scientist Dr Kaelo Seatla, a BHP PhD fellow was awarded an HBNU Fogarty…
BHP conducts COVID-19 study
BHP is living true to its mission of fighting emerging public health challenges through innovative research and capacity building that…
BHP to take part in the Worldwide Week at Harvard University
The Botswana Harvard AIDS Institute Partnership (BHP) has been invited to take part in the commemoration of the Worldwide Week…
CTU,HPTN Team trained on DAIDS Applied Research.
The Botswana Harvard AIDS Institute Partnership (BHP)’s Clinical Trials Unit (CTU) and the HIV Prevention Trials Network (HPTN) sites on…
BHP Scientists participate in Gender Equity in Science Campaign.
Three Botswana Harvard AIDS Institute Partnership (BHP) female scientists recently participated in a three weeks Social Media Campaign dubbed Gender…
BHP Board reflects on racism and research.
The Board of Directors for the Botswana Harvard AIDS Institute Partnership (BHP) led by the Chairman, Prof Roger Shapiro have…
Potlako Plus Study conducts Community Randomization
Botswana Harvard AIDS Institute Partnership (BHP) conducted community randomization on June 04,2020 for the Potlako Plus study. Potlako Plus is a…
BHP resumes recruitment of study participants
The Botswana Harvard AIDS Institute Partnership (BHP) studies have been advised to prudently resume recruitment and enrolment of study participants…
BHP remains resilient amid COVID-19 pandemic
The Deputy Chief Executive Officer (CEO) of the Botswana Harvard AIDS Institute Partnership (BHP) Dr Mompati Mmalane has commended BHP…